Phoenix atherectomy for patients with peripheral artery disease.

ABSTRACT:

Background

Endovascular atherectomy enables minimally invasive plaque removal in peripheral artery disease (PAD).

Aims

We aimed to evaluate the safety and the long-term effectiveness of the Phoenix atherectomy for the treatment of complex and calcified lesions in PAD patients.

Methods

Consecutive all-comer patients with PAD underwent the Phoenix atherectomy. Device safety in terms of perforation and distal embolisation were evaluated. Lesion calcifications were categorised by the Peripheral Arterial Calcium Scoring System (PACSS) and lesion complexity was assessed by the Transatlantic Inter-Society Consensus (TASC). Clinically driven target lesion revascularisation (TLR) was assessed.

Results

A total of 558 lesions were treated in 402 consecutive patients. Clin

SUBMITTER: Giusca S 

PROVIDER: S-EPMC10331978 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature